These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22969286)

  • 1. Resolution of persistent corneal erosion after administration of topical rebamipide.
    Kashima T; Akiyama H; Miura F; Kishi S
    Clin Ophthalmol; 2012; 6():1403-6. PubMed ID: 22969286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical rebamipide improves lid wiper epitheliopathy.
    Itakura H; Kashima T; Itakura M; Akiyama H; Kishi S
    Clin Ophthalmol; 2013; 7():2137-41. PubMed ID: 24204116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.
    Kashima T; Itakura H; Akiyama H; Kishi S
    Clin Ophthalmol; 2014; 8():1003-10. PubMed ID: 24940041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical rebamipide improves the ocular surface in mild lagophthalmos.
    Itakura M; Itakura H; Kashima T; Akiyama H; Kishi S
    Clin Ophthalmol; 2013; 7():1333-8. PubMed ID: 23836962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes.
    Hayashi Y; Toshida H; Matsuzaki Y; Matsui A; Ohta T
    Int Med Case Rep J; 2016; 9():113-6. PubMed ID: 27257394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Shamloo K; Barbarino A; Alfuraih S; Sharma A
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological observation of goblet cells following topical rebamipide treatment of the human ocular surface: A case report.
    Kase S; Shinohara T; Kase M
    Exp Ther Med; 2015 Feb; 9(2):456-458. PubMed ID: 25574215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects.
    Yen MT; Pflugfelder SC; Feuer WJ
    Am J Ophthalmol; 2001 Mar; 131(3):314-23. PubMed ID: 11239863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress.
    Simsek C; Kojima T; Nakamura S; Dogru M; Tsubota K
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.
    Shoji J; Inada N; Tomioka A; Yamagami S
    PLoS One; 2020; 15(11):e0242617. PubMed ID: 33232357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells.
    Takeji Y; Urashima H; Aoki A; Shinohara H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):259-63. PubMed ID: 22335446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model.
    Urashima H; Okamoto T; Takeji Y; Shinohara H; Fujisawa S
    Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of dry eye syndrome: conjunctival graft of the minor salivary gland.
    Güerrissi JO; Belmonte J
    J Craniofac Surg; 2004 Jan; 15(1):6-10. PubMed ID: 14704553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of rebamipide ophthalmic suspension on ocular surface mucins in soft contact lens wearers.
    Shigeyasu C; Yamada M; Akune Y; Fukui M
    Cont Lens Anterior Eye; 2018 Aug; 41(4):357-361. PubMed ID: 29248314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.